1. Home
  2. INUV vs LGVN Comparison

INUV vs LGVN Comparison

Compare INUV & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$0.59

Market Cap

18.0M

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$2.49

Market Cap

21.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INUV
LGVN
Founded
N/A
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.0M
21.4M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
INUV
LGVN
Price
$0.59
$2.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$11.00
$3.00
AVG Volume (30 Days)
164.3K
280.4K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
50.76
EPS
N/A
N/A
Revenue
$86,209,305.00
$709,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$12.89
$10.81
P/E Ratio
N/A
N/A
Revenue Growth
2.88
N/A
52 Week Low
$0.57
$0.48
52 Week High
$4.42
$7.60

Technical Indicators

Market Signals
Indicator
INUV
LGVN
Relative Strength Index (RSI) 30.93 36.32
Support Level N/A $0.61
Resistance Level $1.16 $7.30
Average True Range (ATR) 0.04 0.47
MACD 0.01 -0.52
Stochastic Oscillator 18.47 1.41

Price Performance

Historical Comparison
INUV
LGVN

About INUV Inuvo Inc.

Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: